27th February 2025

A 75-year-old patient with newly diagnosed metastatic prostate cancer is started on long-term bicalutamide monotherapy

A 75-year-old patient with newly diagnosed metastatic prostate cancer is started on long-term bicalutamide monotherapy. After reading about it online, he raises concerns about gynaecomastia. What first-line option should be offered to the patient to prevent gynaecomastia?

Select the SINGLE most appropriate option from the list below. Select ONE option only.